Ghatalia, Pooja <br/><br/>
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.  [electronic resource] 

 -  Current treatment options in oncology  01 2017 
 - 7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1534-6277 
<br/><br/><label>Standard No.: </label>10.1007/s11864-017-0458-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Biomarkers, Tumor<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials as Topic<br/>Humans<br/>Immunologic Factors--pharmacology<br/>Immunomodulation--drug effects<br/>Kidney Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Patient Selection<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome